Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in J Neurol Neurosurg Psychiatry Retrieve available abstracts of 84 articles: HTML format Text format

Single Articles

January 2012
1. KELLY SB , Chaila E, Kinsella K, Duggan M, et al
   Using atypical symptoms and red flags to identify non-demyelinating disease.
   J Neurol Neurosurg Psychiatry. 2012;83:44-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. HUGHES S , Spelman T, Trojano M, Lugaresi A, et al
   The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GOODIN DS , Traboulsee A, Knappertz V, Reder AT, et al
   Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon beta-1b trial in multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. NAGAISHI A , Takagi M, Umemura A, Tanaka M, et al
   Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes.
   J Neurol Neurosurg Psychiatry. 2011;82:1360-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. HILL-CAWTHORNE GA , Button T, Tuohy O, Jones JL, et al
   Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. CALABRESE M , Grossi P, Favaretto A, Romualdi C, et al
   Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
7. KINGWELL E , van der Kop M, Zhao Y, Shirani A, et al
   Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. BATES D , Bartholome E
   Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LUCAS RM , Hughes AM, Lay ML, Ponsonby AL, et al
   Epstein-Barr virus and multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. BENTLEY P , Wang T, Malik O, Nicholas R, et al
    CADASIL with cord involvement associated with a novel and atypical NOTCH3 mutation.
    J Neurol Neurosurg Psychiatry. 2011;82:855-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
11. PENDER MP , Csurhes PA, Pfluger CM, Burrows SR, et al
    CD8 T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
12. GLANZ BI , Healy BC, Hviid LE, Chitnis T, et al
    Cognitive deterioration in patients with early multiple sclerosis: a 5-year study.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CAVANAGH J
    Understanding the biological mechanisms underlying symptoms might help us cross the brain-body divide to the benefit of both.
    J Neurol Neurosurg Psychiatry. 2011;82:709.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
14. TORTORELLA C , Ruggieri M, Di Monte E, Ceci E, et al
    Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. O'GORMAN C , Freeman S, Taylor BV, Butzkueven H, et al
    Familial recurrence risks for multiple sclerosis in Australia.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. ISOSE S , Mori M, Takahashi N, Ito S, et al
    Neurological pictures. Clumsy hand syndrome due to a localised cortical lesion in the primary sensory cortex in neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2011;82:559-60.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
17. SIMPSON S JR , Blizzard L, Otahal P, Van der Mei I, et al
    Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KHAN O , Tselis A
    Chronic cerebrospinal venous insufficiency and multiple sclerosis: science or science fiction?
    J Neurol Neurosurg Psychiatry. 2011;82:355.
    PubMed     Text format     Related articles   
    
    
    
    
19. MAYER CA , Pfeilschifter W, Lorenz MW, Nedelmann M, et al
    The perfect crime? CCSVI not leaving a trace in MS.
    J Neurol Neurosurg Psychiatry. 2011;82:436-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. TUR C , Khaleeli Z, Ciccarelli O, Altmann DR, et al
    Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.
    J Neurol Neurosurg Psychiatry. 2011;82:423-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BONATI U , Fisniku LK, Altmann DR, Yiannakas MC, et al
    Cervical cord and brain grey matter atrophy independently associate with long-term MS disability.
    J Neurol Neurosurg Psychiatry. 2011;82:471-2.
    PubMed     Text format     Related articles   
    
    
    
    
22. PETZOLD A , Marignier R, Verbeek MM, Confavreux C, et al
    Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases.
    J Neurol Neurosurg Psychiatry. 2011;82:467-9.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
23. EDAN G , Comi G, Le Page E, Leray E, et al
    Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. LIGUORI M , Meier DS, Hildenbrand P, Healy BC, et al
    One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CONNICK P , Kolappan M, Bak TH, Chandran S, et al
    Verbal fluency as a rapid screening test for cognitive impairment in progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. TAYLOR BV
    Ireland: a fine place for multiple sclerosis research.
    J Neurol Neurosurg Psychiatry. 2011;82:237.
    PubMed     Text format     Related articles   
    
    
    
    
27. GOUT O , Lebrun-Frenay C, Labauge P, Le Page GE, et al
    Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event.
    J Neurol Neurosurg Psychiatry. 2011;82:323-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
28. JENKINS TM , Ciccarelli O, Atzori M, Wheeler-Kingshott CA, et al
    Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. GOLD SM , Kruger S, Ziegler KJ, Krieger T, et al
    Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. EBERS G
    Tasmania: state of MS in Australia.
    J Neurol Neurosurg Psychiatry. 2011;82:119.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
31. LONERGAN R , Kinsella K, Fitzpatrick P, Brady J, et al
    Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. RAMAGOPALAN SV , Hoang U, Seagroatt V, Handel A, et al
    Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study.
    J Neurol Neurosurg Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
33. NIINO M
    Vitamin D metabolites and multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
34. ABSINTA M , Rocca MA, Moiola L, Ghezzi A, et al
    Brain macro- and microscopic damage in patients with paediatric MS.
    J Neurol Neurosurg Psychiatry. 2010;81:1357-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
35. SIMPSON S JR , Pittas F, van der Mei I, Blizzard L, et al
    Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. WEINSTOCK-GUTTMAN B , Zivadinov R, Qu J, Cookfair D, et al
    Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. DOBSON R , Feldmann M, Thompson AJ, Giovannoni G, et al
    POI18 Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010;81:e57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. INGRAM G , Bugert JJ, Loveless S, Robertson NP, et al
    POI19 EBNA-1 IgG is not a reliable clinical marker of multiple sclerosis disease activity.
    J Neurol Neurosurg Psychiatry. 2010;81:e57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. JOHNSTON J , Ali K, Pearson OR, Rickards C, et al
    POI14 Multiple sclerosis: a potential association with anti-N-methyl-d-aspartate receptor encephalitis.
    J Neurol Neurosurg Psychiatry. 2010;81:e56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MATTHEWS L , Palace J, Deoni S, Leite MI, et al
    POI16 Comparing MRI measures of myelin integrity as surrogate markers for the clinical expression of primary progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010;81:e56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. KELLY S , Turbridy N, Hutchinson
    POI10 Using atypical symptoms to predict nondemyelinating disease in patients as "query multiple sclerosis".
    J Neurol Neurosurg Psychiatry. 2010;81:e55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. CHATAWAY J , Anderson V, Chan D, Frost C, et al
    POI11 The MS-STAT trial: a phase II trial of high-dose simvastatin for secondary progressive multiple sclerosis: baseline trial profile.
    J Neurol Neurosurg Psychiatry. 2010;81:e55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. MAGUIRE M , Newman P, Fuller J
    POI13 Acute respiratory failure in a multiple sclerosis relapse: successful treatment with plasma exchange.
    J Neurol Neurosurg Psychiatry. 2010;81:e55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. INGRAM G , Morgan BP, Robertson NP, Hakobyan S, et al
    POI08 Serum C4a levels in multiple sclerosis correlate with disease activity.
    J Neurol Neurosurg Psychiatry. 2010;81:e54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MOLLOY A , Kinsella K, Turbridy N, Hutchinson M, et al
    POI09 Trends in BK and JC polyomavirus and relationship to CD4+/CD8+ ratio in patients with relapsing remitting multiple sclerosis on natalizumab therapy.
    J Neurol Neurosurg Psychiatry. 2010;81:e54-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. NICHOLAS R , D'Arcy C, Muraro P, McGuigan C, et al
    POI03 Using natalizumab in highly active relapsing remitting multiple sclerosis in the UK.
    J Neurol Neurosurg Psychiatry. 2010;81:e53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LANGDON D , Russell N, Field A, Fox L, et al
    POI05 StayingSmart--an online web resource about cognitive deficits in multiple sclerosis for patients, carers and professionals.
    J Neurol Neurosurg Psychiatry. 2010;81:e53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. ARUN T , Smith S, Weir AP, Palace J, et al
    POI01 Direct comparison of multiple nonlesional imaging measures to assess their power to measure treatment effects over 1 year in primary progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010;81:e52-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. COSSBURN M , Hirst CL, Pickersgill TP, Robertson NP, et al
    PAW27 Age-dependent phenotypic variation of multiple sclerosis at disease onset.
    J Neurol Neurosurg Psychiatry. 2010;81:e31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. EBERS G , Neuhaus A, Muraro P, Daumer M, et al
    PAW28 The natural history of multiple sclerosis, a geographically based study. 10: relapses and long-term disability.
    J Neurol Neurosurg Psychiatry. 2010;81:e31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LONERGAN R , Jordan S, Hagan R, Kinsella K, et al
    PAW29 Multiple sclerosis in Ireland: regional variation in prevalence and vitamin D status.
    J Neurol Neurosurg Psychiatry. 2010;81:e31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. SAWCER S
    PAW30 Impact of genome-wide association screening on the genetics of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010;81:e31-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. KARPHA I , Ramtahal J, Boggild M, Evans F, et al
    PAW25 A single-centre, pilot, randomised controlled trial of recombinant human erythropoietin in primary progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010;81:e30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. PANICKER J , Khan S, Game X, Dalton C, et al
    PAW26 Are the beneficial effects of Botulinum toxin for refractory detrusor overactivity in multiple sclerosis sustained with repeat injections?
    J Neurol Neurosurg Psychiatry. 2010;81:e30-1.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. MIHALOVA T , Ban M, Baker A, Abraham R, et al
    PATU11 IL2RA and CD226 genotypes influence multiple sclerosis disease outcome.
    J Neurol Neurosurg Psychiatry. 2010;81:e27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. COSSBURN MD , Pace AA, Jones J, Ali R, et al
    PATU7 Autoimmune diseases after alemtuzumab treatment for multiple sclerosis: findings from a multicentre UK cohort.
    J Neurol Neurosurg Psychiatry. 2010;81:e26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. NOVIK V , Kuznetsov AN, Kurbatova KA, Kruglina RV, et al
    PATU8 Analysis of outcomes of high-dose immunosuppressive therapy with autologous stem cell transplantation in 156 patients with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010;81:e26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. BAKER K , Pickersgill T, Robertson N, Cossburn M, et al
    PATU9 Seasonal variation in multiple sclerosis relapse.
    J Neurol Neurosurg Psychiatry. 2010;81:e26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. JACOB S , Karim A, Drayson M, Mitchell J, et al
    PATH58 Kappa and lambda free light chains in CSF in the differential diagnosis of multiple sclerosis and its correlation with clinical subtypes.
    J Neurol Neurosurg Psychiatry. 2010;81:e23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
60. ZELLER D , Dang SY, Stefan K, Biller A, et al
    Functional role of ipsilateral motor areas in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. WATTJES MP , van Oosten BW, de Graaf WL, Seewann A, et al
    No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. WASAY M , Rizvi F, Azeemuddin M, Yousuf A, et al
    Incidental MRI lesions suggestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. REUTER F , Zaaraoui W, Crespy L, Faivre A, et al
    Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. RAZ N , Vaknin A, Chokron S, Ben-Hur T, et al
    Functional MRI as a tool for assessing chiasmal visual defect in a patient with neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2010;81:1174-5.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
65. THEVATHASAN W , Schweder P, Joint C, Ray N, et al
    Permanent tremor reduction during thalamic stimulation in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. LUKAS C , Minneboo A, de Groot V, Moraal B, et al
    Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. CHATAWAY J
    Progression is likely to occur earlier in young men with motor onset symptoms.
    J Neurol Neurosurg Psychiatry. 2010;81:944-5.
    PubMed     Text format     Related articles   
    
    
    
    
68. GONZALEZ SANCHEZ JJ , Nora JE, de Notaris M, Arboix JR, et al
    A case of malignant monophasic multiple sclerosis (Marburg's disease type) successfully treated with decompressive hemicraniectomy.
    J Neurol Neurosurg Psychiatry. 2010;81:1056-7.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
69. GLAD SB , Nyland H, Aarseth JH, Riise T, et al
    How long can you keep working with benign multiple sclerosis?
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. HANDEL AE , Ramagopalan SV
    Multiple sclerosis and risk of cancer: a meta-analysis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
71. KOCH M , Kingwell E, Rieckmann P, Tremlett H, et al
    The natural history of secondary progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. BODINI B , Battaglini M, De Stefano N, Khaleeli Z, et al
    T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
73. FOWLER CJ
    The effectiveness of bladder rehabilitation in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
74. MILLS RJ , Young CA, Pallant JF, Tennant A, et al
    Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. QIU W , Raven S, Wu JS, Bundell C, et al
    Hypothalamic lesions in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. RINALDI L , Rinaldi F, Perini P, Calabrese M, et al
    No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. UZAWA A , Mori M, Ito S, Kuwabara S, et al
    Isolated abducens and facial nerve palsies due to a facial collicular plaque in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
78. KHAN F , Pallant JF, Pallant JI, Brand C, et al
    A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. CHARD DT , Dalton CM, Swanton J, Fisniku LK, et al
    MRI only conversion to multiple sclerosis following a clinically isolated syndrome.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
80. AUDOIN B , Zaaraoui W, Reuter F, Rico A, et al
    Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. DE SEZE J , Blanc F, Kremer S, Collongues N, et al
    Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2010;81:409-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. VALSASINA P , Agosta F, Absinta M, Sala S, et al
    Cervical cord functional MRI changes in relapse-onset MS patients.
    J Neurol Neurosurg Psychiatry. 2010;81:405-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
83. RABADI MH , Kundi S, Brett D, Padmanabhan R, et al
    Neurological pictures. Primary Sjogren syndrome presenting as neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2010;81:213-4.
    PubMed     Text format     Related articles   
    
    
    
    
84. DI FILIPPO M , Anderson VM, Altmann DR, Swanton JK, et al
    Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.
    J Neurol Neurosurg Psychiatry. 2010;81:204-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: